Genpact Ltd. announced that it has been awarded a five-year contract extension by GlaxoSmithKline (GSK) for finance and accounting services. Under this agreement, the company will continue to deliver global services such as accounts payable, record-to-report, and order-to-cash across several global regions, supporting GSK's drive to standardize core business processes and services.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.45 USD | +1.82% |
|
+4.51% | -6.51% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.51% | 5.84B | |
+19.76% | 73.23B | |
+10.89% | 18.02B | |
+18.76% | 14.53B | |
+16.05% | 13.13B | |
+14.46% | 10.18B | |
-15.15% | 7.28B | |
+7.29% | 5.38B | |
+4.60% | 5.33B | |
+11.75% | 4.73B |
- Stock Market
- Equities
- G Stock
- News Genpact Limited
- Genpact Ltd. Signs Five-Year Contract Extension with GlaxoSmithKline for Finance and Accounting Business Process Management Services